{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.12.1044",
  "meta": {
    "profile": [ "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-computablevalueset" ]
  },
  "extension": [ {
    "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability",
    "valueString": "computable"
  }, {
    "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel",
    "valueString": "structured"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-warning",
    "valueMarkdown": "CAUTION: The compose element in this ValueSet resource was inferred from the expansion element. It is NOT an authoritative definition of the value set and is provided only for convenience for systems that assume a compose will be present."
  } ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1044",
  "identifier": [ {
    "system": "urn:ietf:rfc:3986",
    "value": "2.16.840.1.113883.3.464.1003.110.12.1044"
  } ],
  "version": "20170504",
  "name": "InfluenzaVaccineAdministered",
  "title": "Influenza Vaccine Administered",
  "status": "active",
  "experimental": false,
  "publisher": "NLM",
  "compose": {
    "include": [ {
      "system": "http://snomed.info/sct",
      "version": "2020-09",
      "concept": [ {
        "code": "86198006",
        "display": "Administration of vaccine product containing only Influenza virus antigen (procedure)"
      } ]
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "concept": [ {
        "code": "90655",
        "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
      }, {
        "code": "90657",
        "display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
      }, {
        "code": "90661",
        "display": "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
      }, {
        "code": "90662",
        "display": "Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"
      }, {
        "code": "90673",
        "display": "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
      }, {
        "code": "90685",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
      }, {
        "code": "90686",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
      }, {
        "code": "90687",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
      }, {
        "code": "90688",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
      } ]
    } ]
  },
  "expansion": {
    "identifier": "20210506",
    "timestamp": "2021-07-19T17:22:06-06:00",
    "contains": [ {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90655",
      "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90657",
      "display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90661",
      "display": "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90662",
      "display": "Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90673",
      "display": "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90685",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90686",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90687",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2021",
      "code": "90688",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2020-09",
      "code": "86198006",
      "display": "Administration of vaccine product containing only Influenza virus antigen (procedure)"
    } ]
  }
}